Table 1.
Recommended screening instruments for Alzheimer's disease (AD) screen recommended by De Roeck et al22
| Duration (min) | Memory | Language | Orientation | Executive functions | Praxis | Visuospatial abilities | Attention | Suitable for | Specificity for AD | Sensitivity for AD | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MIS | 4 | Y | Population‐based screen | 97% | 86% | ||||||
| Clinic | 97% | NR | |||||||||
| MoCA | 10‐15 | Y | Y | Y | Y | Y | Y | Y | Population‐based screen | 82% | 97% |
| Clinic | 91% | 93% | |||||||||
| MES | 7 | Y | Y | Clinic | 99% | 99% |
AD, Alzheimer's disease; MES, Memory and Executive Screening; MIS, Memory Impairment Screen; MoCA, Montreal Cognitive Assessment; NR, not reported; Y, indicated function measured.